Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Papillary renal cell carcinoma, sporadic 1Osteoradionecrosis 1Mouth Neoplasms 1Hereditary leiomyomatosis and renal cell cancer 1Glioma 1Fallopian Tube Mucinous Adenocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Magnetic Resonance Spectroscopy 9Specimen Handling 8Cisplatin 5Cetuximab 5Platinum 41,2-diaminocyclohexaneplatinum II citrate 4cemiplimab 3Radiotherapy 3Immunoglobulin G 3Disulfides 3Biopsy 3(225)Ac-DOTA-c(RGDyK) 3pembrolizumab 2Radiotherapy, Intensity-Modulated 2Radiation 2Nivolumab 2Carboplatin 2Bevacizumab 2trastuzumab deruxtecan 1temsirolimus 1niraparib 1ipatasertib 1durvalumab 1dostarlimab 1cabozantinib 1atezolizumab 1Valproic Acid 1Ultrasonography 1Transurethral Resection of Bladder 1Tramadol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mouth Neoplasms × Contrast Media × 30 days × Clear all
NCT04265430 2026-05-22

Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors

M.D. Anderson Cancer Center

Phase 4 Recruiting
425 enrolled
Head & Neck

Mouth Neoplasms, Osteoradionecrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡